FDA Clears New Capabilities for Diabetes App BlueStar FDA Clears New Capabilities for Diabetes App BlueStar

The app-based system can now make insulin dose recommendations based on continuous glucose monitor (CGM) data.Medscape Medical News
Source: Medscape Diabetes Headlines - Category: Endocrinology Tags: Diabetes & Endocrinology News Alert Source Type: news